capecitabine has been researched along with Stevens-Johnson Syndrome in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Karthikeyan, K; Madhu, CS; Sameera, KV; Shaji, S; Swetha, MAC | 1 |
Jadhav, P; Rogers, JE; Shroff, R | 1 |
Kilickap, S; Sendur, MA | 1 |
4 other study(ies) available for capecitabine and Stevens-Johnson Syndrome
Article | Year |
---|---|
Capecitabine induced Steven-Johnson syndrome: A rare case report.
Topics: Aged; Antineoplastic Agents; Capecitabine; Fluorouracil; Humans; Male; Neoplasms; Stevens-Johnson Syndrome | 2022 |
Capecitabine: toxic epidermal necrolysis and Stevens-Johnson syndrome.
Topics: Antimetabolites, Antineoplastic; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Fluorouracil; Humans; Risk Assessment; Risk Factors; Stevens-Johnson Syndrome; Time Factors; United Kingdom | 2014 |
A Case Report-Stevens-Johnson Syndrome as an Adverse Effect of Capecitabine.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Capecitabine; Duodenal Neoplasms; Humans; Male; Middle Aged; Pancreatic Neoplasms; Stevens-Johnson Syndrome | 2018 |
Stevens-Johnson syndrome after treatment with capecitabine.
Topics: Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Female; Fluorouracil; Humans; Middle Aged; Stevens-Johnson Syndrome | 2008 |